driven by the PitchBook Platform
Developer of drugs designed to treat lung cancer. The company's drugs include two products such as the ORA101 for non-small cell lung cancer and ORA102 for age-related macular degeneration, enabling doctors to treat lung cancer.
You’re viewing a free company profile from the PitchBook Platform. To explore Ora Bio’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.